Product Information
FML FORTE 0.25% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $32.1856 per ML under NDC 11980022810. Its NADAC has been published 645 times since Nov 28, 2013.
FDA first approved this application on Apr 23, 1986.
Strength
2.5 mg/mL
Manufacturer
Allergan, Inc.NDC
11980022810
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
7/22/2026
Active Ingredients
FLUOROMETHOLONEApproval Type
New Drug (NDA)
FDA Application
NDA019216FDA Approved
4/23/1986
On Market Since
5/1/1986
Pharmacological Classes
Price Statistics
The NADAC for FML FORTE 0.25% EYE DROPS has been published 645 times since Nov 28, 2013, and over the history we have for it it has risen 450.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $32.1856 per ML |
|---|---|
| All-time high | $33.2073 (Jan 12, 2022) |
| All-time low | $5.8460 (Nov 28, 2013) |
| 52-week high | $32.3314 |
| 52-week low | $32.1266 |
| Median price | $31.6260 |
| Average price | $28.4244 |
| Largest weekly change | +200.2% (Dec 5, 2013) |
| Weeks tracked | 645 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluorometholone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FML FORTE 0.25% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for FML FORTE 0.25% EYE DROPS, manufactured by Allergan, Inc., is $32.1856 per ML (NDC 11980022810), effective Sep 30, 2026.
How has the price of FML FORTE 0.25% EYE DROPS changed over time?
Over the history we have for it, the NADAC for FML FORTE 0.25% EYE DROPS has risen 450.6%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FML FORTE 0.25% EYE DROPS?
Since Nov 28, 2013, the NADAC for FML FORTE 0.25% EYE DROPS has ranged from a low of $5.8460 (Nov 28, 2013) to a high of $33.2073 (Jan 12, 2022), with a median of $31.6260 per ML.
Are there cheaper alternatives to FML FORTE 0.25% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FML FORTE 0.25% EYE DROPS, is $32.1483 per ML — about 0% below FML FORTE 0.25% EYE DROPS.
Who manufactures FML FORTE 0.25% EYE DROPS?
FML FORTE 0.25% EYE DROPS (NDC 11980022810) is labeled by Allergan, Inc., and CMS classifies it as a brand product.